Compare Aurora Cannabis Inc (ACB) vs Procter & Gamble Co (PG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Aurora Cannabis Inc vs Procter & Gamble Co — how do they compare? Aurora Cannabis Inc trades at $2.67 (market cap $165.36M), while Procter & Gamble Co trades at $148.71 (market cap $355.69B). The key difference: Procter & Gamble Co is far larger — about 2151× Aurora Cannabis Inc's market cap, and Procter & Gamble Co pays a 2.79% dividend while Aurora Cannabis Inc pays none. Which is the better fit depends on your goals.
| ACB | PG | |
|---|---|---|
Market Cap | $165.36M | $355.69B |
Sector | Health | Consumer Staples |
52-Week High | $6.23 | $167.18 |
52-Week Low | $2.67 | $138.10 |
Enterprise Value | $99.82M | $381.17B |
Volume | — | 6,423,436 |
Dividend Yield | — | 2.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.
The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.
Procter & Gamble (PG) trades at $148.9, down 0.27% on the day, with a bullish technical outlook supported by moving averages and key support at $148. The company reported consistent earnings beats, with Q1 2026 EPS of $1.59 exceeding the $1.56 estimate, and maintains strong cash flow from operations of $17.82B in 2025. Recent developments include a new WNBA partnership and a $1.09 dividend payment scheduled for May 2026.
PG offers stable growth with a 19.16% net income margin and a consensus price target of $159.88, implying 7% upside. Risks include premium valuations (P/E of 22.33) amid modest revenue growth and economic sensitivity. Analyst sentiment is bullish (56% buy ratings), but investors should monitor competitive pressures and inflation impacts on margins.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aurora Cannabis Inc
Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.
Read more on ACB →About Procter & Gamble Co
The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →
